Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2024Current Medicinal Chemistry

Identification and Verification of Metabolism-related Immunotherapy Features and Prognosis in Lung Adenocarcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJunfang LuoJAJinlu AnRJRongyan Jia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Luo et al. (2024) studied this question.

synapsesocial.com/papers/68e73cbeb6db6435876b65cdhttps://doi.org/10.2174/0109298673293414240314043529
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prediction of Prognosis, Efficacy of Lung Adenocarcinoma by Machine Learning Model Based on Immune and Metabolic Related Genes2024
  2. 2Construction of a Prognostic Model for Lung Adenocarcinoma Based on Nucleotide Metabolism-Related Genes and Bioinformatics Analysis2024
  3. 3Exploring Prognostic Biomarkers in Lung Adenocarcinoma: Strategic Integration of Metabolic Subtyping and Ubiquitination Pathways2026
  4. 4B21-04 A Prognostic Risk Model Based on the Tumor Microenvironment in Lung Adenocarcinoma2026
  5. 5Identification of a novel nucleotide metabolism-related signature for predicting lung adenocarcinoma prognosis2025